Payers and providers now expect RWE to complement trial efficacy by demonstrating effectiveness, utilization impact, and ROI ...
Formulary positioning and benefit design frequently determine utilization, as weak placement or reimbursement dynamics can ...
Integrated direct-to-patient models use AI-enabled eBenefits/eVerification plus real-time claims adjudication to surface ...
Supreme Court inaction leaves intact lower-court rulings rejecting takings and compelled-speech theories against “fair price” designations in Medicare price negotiation. Courts emphasized ...
Jeremy Richardson explains how direct-to-patient models increase drug pricing transparency and demonstrate value.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results